ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PHAT Phathom Pharmaceuticals Inc

9.98
0.22 (2.25%)
Last Updated: 11:36:47
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Phathom Pharmaceuticals Inc PHAT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.22 2.25% 9.98 11:36:47
Open Price Low Price High Price Close Price Previous Close
10.35 9.88 10.37 9.76
more quote information »

Recent News

Date Time Source Heading
4/29/202407:00GLOBEPhathom Pharmaceuticals to Report First Quarter 2024..
4/03/202407:00GLOBEPhathom Pharmaceuticals to Participate in the 23rd Annual..
3/26/202407:00GLOBEPhathom Pharmaceuticals Launches Direct-to-Consumer..
3/07/202415:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/07/202407:06EDGAR2Form 8-K - Current report
3/07/202407:00GLOBEPhathom Pharmaceuticals Reports Fourth Quarter and Full Year..
2/29/202407:00GLOBEPhathom Pharmaceuticals to Report Fourth Quarter and Full..
2/13/202407:05EDGAR2Form 8-K - Current report
2/13/202407:00GLOBEPhathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan)..
1/31/202407:00GLOBEPhathom Pharmaceuticals to Present at the Guggenheim..
1/22/202419:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202315:05EDGAR2Form 8-K - Current report
12/14/202307:05EDGAR2Form 8-K - Current report
12/14/202307:00GLOBEPhathom Pharmaceuticals Announces Expansion of Existing Loan..
12/06/202307:05EDGAR2Form 8-K - Current report
12/06/202307:00GLOBEPhathom Pharmaceuticals Announces FDA Acceptance for Filing..
11/28/202307:06EDGAR2Form 8-K - Current report
11/28/202307:00GLOBEPhathom Pharmaceuticals Announces Commercial Availability of..
11/19/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/09/202315:02EDGAR2Form S-3 - Registration statement under Securities Act of..
11/09/202307:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202307:05EDGAR2Form 8-K - Current report
11/09/202307:00GLOBEPhathom Pharmaceuticals Reports Third Quarter 2023 Results..
11/08/202318:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202315:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202316:50DJNPhathom Pharmaceuticals Gets FDA Approval for Voquezna..
11/01/202316:06EDGAR2Form 8-K - Current report
11/01/202316:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of VOQUEZNA®..
10/30/202307:05EDGAR2Form 8-K - Current report
10/30/202307:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of..
10/25/202307:01GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
9/26/202307:05EDGAR2Form 8-K - Current report
9/26/202307:01GLOBEPhathom Pharmaceuticals Announces Vonoprazan NDA Submission..
9/05/202307:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
8/21/202307:07EDGAR2Form 8-K - Current report
8/21/202307:00GLOBEPhathom Pharmaceuticals Announces Submission of Six-Month..
8/10/202315:02EDGAR2Form 8-K - Current report
8/10/202307:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202307:01GLOBEPhathom Pharmaceuticals Reports Second Quarter 2023 Results
7/17/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/17/202315:04EDGAR2Form 8-K - Current report
7/17/202315:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
6/12/202308:04DJNFDA Accepts Phathom Pharmaceuticals' Resubmission for..
6/12/202307:01GLOBEPhathom Pharmaceuticals Announces FDA Acceptance of NDA..
6/09/202315:01GLOBEPhathom Pharmaceuticals Announces Closing of Underwriters’..
6/09/202304:45PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
6/07/202304:45PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
6/02/202304:45PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
6/01/202307:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
5/30/202304:00PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..

Your Recent History

Delayed Upgrade Clock